Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/14/2003EP1068208B1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them
05/14/2003EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
05/14/2003EP0954521B1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0932609B1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003EP0830369B1 Nor-pregnanes for inducing hypothalamic effects
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0799314B1 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418213A Crgstalline form II of cabergoline
05/14/2003CN1418206A Method for preparation of 5-cyano-1 (4-fluorophenyl) -1, 3-dihydroisobenzofurans
05/14/2003CN1418205A method for preparation of citalopram
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418109A Drugs for complications of diabetes and neuropathy and utilization thereof
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418101A Method of increasing alertness by administration of vomeropherin and vomeropherin-emitting alarm device
05/14/2003CN1418100A Compounds with 5-HT activity useful for controlling visual field loss
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418094A Use of deramciclane for treatment of anxiety and depression
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1417218A Kaempferol derivative and its medicinal use
05/14/2003CN1417209A Tetrahydroquinoline ketopiperidine compounds and their prepn and use
05/14/2003CN1416888A White peony and licorice extract and its prepn process
05/14/2003CN1416884A Melatonin composition with soporific effect and its prepn
05/14/2003CN1416881A Medicine composition for treating depression and its prepn
05/14/2003CN1416880A New use of powder for regulating liver and spleen and its active part
05/14/2003CN1416877A Chinese herbal medicine for stopping drug addiction
05/14/2003CN1416874A Medicated pillow and its making process
05/14/2003CN1416857A Efficient Chinese medicine and western medicine combined sobering up agent
05/14/2003CN1416838A Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process
05/14/2003CN1416815A Compound prepn containing prostaglandin E1, prostaglandin A1 and prostaglandin B1 and its prepn process and use
05/14/2003CN1108158C Analgesic composition
05/13/2003US6564152 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists
05/13/2003US6562980 Method for producing 5-aryloxymethyl-2-oxazolidinones
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562867 Halogenated 2-phenyl-1,2-ethanediol monocarbamate derivatives
05/13/2003US6562865 Composition comprising a tramadol material and an anticonvulsant drug
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562862 Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562847 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562839 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562810 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors
05/13/2003US6562809 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor
05/13/2003US6562783 Therapy for Alzheimer's disease
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562335 NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
05/13/2003CA2259655C 1,4-di-sustituted piperidines as muscarinic antagonists
05/13/2003CA2202992C Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2048980C 1-(pyridinylalkyl)-1h-indoles, indolines and related analogs
05/09/2003CA2464707A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/08/2003WO2003038118A1 Method of evaluating phosphatase inhibitors
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038090A1 Method of inducing diffrentiation of immortalized mesodermal stem cells into nervous system cells
05/08/2003WO2003038075A1 Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
05/08/2003WO2003038074A1 Method of inducing differentiation of mesoblast stem cells or es cells into nerve system cells
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038030A1 Device with recessed tracks for forming a cellular network
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037905A1 Silicon compounds
05/08/2003WO2003037904A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
05/08/2003WO2003037900A2 Pyrazolopyrimidines
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037890A2 Piperidines
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 1833